Open AccessEffect of ibrutinib on CCR7 expression and functionality in chronic lymphocytic leukemia, a novel therapeutic anti-CCR7 antibody.
Author(s) -
Immunological Immed S.L.,
Madrid Medicin Products,
Tamara MateuAlbero,
Raque Juárez-Sánchez,
Cecilia MuñozCalleja,
Carlos Cuesta-Mateos,
Fernando Terrón,
Javier Loscertales,
Wim Mol
Publication year - 2021
Publication title -
ibj plus
Language(s) - English
Resource type - Journals
ISSN - 2531-0151
DOI - 10.24217/2531-0151.21v1s4.00040
Subject(s) - ibrutinib , chronic lymphocytic leukemia , c c chemokine receptor type 7 , antibody , cancer research , leukemia , medicine , immunology , receptor , chemokine receptor , chemokine